ARDEN HILLS, Minn. , Aug. 10, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced financial results for its second Read More
Press Releases
Aug 10, 2020
Summary ToggleIntriCon Reports Second Quarter 2020 Results
Jul 27, 2020
Summary ToggleIntriCon to Announce 2020 Second-Quarter Results on Monday, August 10, 2020
ARDEN HILLS, Minn. , July 27, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2020 second-quarter results on Monday, August 10, 2020 Read More
Jun 25, 2020
Summary ToggleIntriCon Announces Chief Executive Officer Transition
J. Scott Longval to Succeed Mark Gorder as President and CEO, Effective October 1, 2020 ARDEN HILLS, Minn. , June 25, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today Read More
May 19, 2020
Summary ToggleIntriCon Reports First Quarter 2020 Results
ARDEN HILLS, Minn. , May 19, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced financial results for its first quarter ended March 31, 2020 . Read More
May 19, 2020
Summary ToggleIntriCon Acquires Emerald Medical Services
Synergistic joint development and manufacturing capability expands market opportunity in surgical navigation Provides immediate access to technology platform serving new high growth medical end-markets with complex interventional catheters Accretive transaction delivers long-term revenue growth Read More
May 11, 2020
Summary ToggleIntriCon to Announce 2020 First-Quarter Results on Tuesday, May 19, 2020
ARDEN HILLS, Minn. , May 11, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2020 first-quarter results on Tuesday, May 19, 2020 , at Read More
Apr 30, 2020
Summary ToggleIntriCon Announces Appointment of Sara Hill as Chief Human Resource Officer
ARDEN HILLS, Minn. , April 30, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced Sara Hill has been appointed Chief Human Resource Officer. Read More
Apr 07, 2020
Summary ToggleINTRICON OFFERS COVID-19 RELATED BUSINESS UPDATE
Provides Preliminary First Quarter 2020 Results; Withdraws Full Year 2020 Guidance ARDEN HILLS, Minn. , April 07, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today Read More
Mar 31, 2020
Summary ToggleIntriCon Corporation Announces Change to Virtual Meeting Format for its Annual Meeting of Shareholders to be Held on April 28, 2020
ARDEN HILLS, Minn , March 31, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced a change in the location of its Annual Meeting of Shareholders to be held on Read More
Mar 19, 2020
Summary ToggleIntriCon Appoints Heather Rider to its Board of Directors
ARDEN HILLS, Minn. , March 19, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN) , a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced the appointment of Heather Rider to the company’s Board of Directors, effective Read More